Efficient Isothermal Titration Calorimetry Technique Identifies Direct Interaction of Small Molecule Inhibitors with the Target Protein

被引:11
|
作者
Gal, Maayan [1 ]
Bloch, Itai [1 ]
Shechter, Nelia [1 ]
Romanenko, Olga [1 ]
Shir, Ofer M. [1 ]
机构
[1] Migal Galilee Res Ctr, Kyriat Shmona, Israel
关键词
Drug screening; fluorescence polarization (FP); isothermal titration calorimetry (ITC); nuclear magnetic resonance spectroscopy (NMR); protein-protein interactions; DRUG DISCOVERY; HIGH-THROUGHPUT; CONFORMATIONAL COVERAGE; FLEXIBILITY; DOCKING; BINDING; VALIDATION; BIOLOGY;
D O I
10.2174/1386207319666151203001529
中图分类号
Q5 [生物化学];
学科分类号
071010 ; 081704 ;
摘要
Protein-protein interactions (PPI) play a critical role in regulating many cellular processes. Finding novel PPI inhibitors that interfere with specific binding of two proteins is considered a great challenge, mainly due to the complexity involved in characterizing multi-molecular systems and limited understanding of the physical principles governing PPIs. Here we show that the combination of virtual screening techniques, which are capable of filtering a large library of potential small molecule inhibitors, and a unique secondary screening by isothermal titration calorimetry, a label-free method capable of observing direct interactions, is an efficient tool for finding such an inhibitor. In this study we applied this strategy in a search for a small molecule capable of interfering with the interaction of the tumor-suppressor p53 and the E3-ligase MDM2. We virtually screened a library of 15 million small molecules that were filtered to a final set of 80 virtual hits. Our in vitro experimental assay, designed to validate the activity of mixtures of compounds by isothermal titration calorimetry, was used to identify an active molecule against MDM2. At the end of the process the small molecule (4S, 7R)-4-(4-chlorophenyl)-5-hydroxy-2,7-dimethyl-N-(6-methylpyridin-2-yl)-4,6,7,8 tetrahydrIoquinoline-3-carboxamide was found to bind MDM2 with a dissociation constant of similar to 2 mu M. Following the identification of this single bioactive compound, spectroscopic measurements were used to further characterize the interaction of the small molecule with the target protein. 2D NMR spectroscopy was used to map the binding region of the small molecule, and fluorescence polarization measurement confirmed that it indeed competes with p53.
引用
收藏
页码:4 / 13
页数:10
相关论文
共 43 条
  • [41] New tools for carbohydrate sulfation analysis: heparan sulfate 2-O-sulfotransferase (HS2ST) is a target for small-molecule protein kinase inhibitors
    Byrne, Dominic P.
    Li, Yong
    Ramakrishnan, Krithika
    Barsukov, Igor L.
    Yates, Edwin A.
    Eyers, Claire E.
    Papy-Garcia, Dulce
    Chantepie, Sandrine
    Pagadala, Vijayakanth
    Liu, Jian
    Wells, Carrow
    Drewry, David H.
    Zuercher, William J.
    Berry, Neil G.
    Fernig, David G.
    Eyers, Patrick A.
    BIOCHEMICAL JOURNAL, 2018, 475 : 2417 - 2433
  • [42] Virtual screening of ultra-large chemical libraries identifies cell-permeable small-molecule inhibitors of a "non-druggable" target, STAT3 N-terminal domain
    Bonilla, Pedro Andrade
    Hoop, Cody L.
    Stefanisko, Karen
    Tarasov, Sergey G.
    Sinha, Sourav
    Nicklaus, Marc C.
    Tarasova, Nadya I.
    FRONTIERS IN ONCOLOGY, 2023, 13
  • [43] Cheminformatics-aided discovery of small-molecule Protein-Protein Interaction (PPI) dual inhibitors of Tumor Necrosis Factor (TNF) and Receptor Activator of NF-κB Ligand (RANKL)
    Melagraki, Georgia
    Ntougkos, Evangelos
    Rinotas, Vagelis
    Papaneophytou, Christos
    Leonis, Georgios
    Mavromoustakos, Thomas
    Kontopidis, George
    Douni, Eleni
    Afantitis, Antreas
    Kollias, George
    PLOS COMPUTATIONAL BIOLOGY, 2017, 13 (04)